REDUCE LAP-HF II Corvia Atrial Shunt 2-Year Outcomes | Clinician Commentary
Published: 28 June 2023
-
Views:
441
-
Likes:
7
-
Views:
441
-
Likes:
7
-
Up Next -
3m 9sPart 1 | Session 2 Interview with Prof Maja Cikes
Overview
Prof Finn Gustafsson (Copenhagen University Hospital, Copenhagen, DK) and Prof Maja Cikes (University Hospital Centre Zagreb, Zagreb, HR) discuss the 2-year outcomes of the REDUCE LAP-HF II trial evaluating the Corvia Atrial Shunt. These interviews shed light on the potential longer-term benefits of the device and its impact on properly selected patients with heart failure with preserved ejection fraction (HFpEF).
Prof Gustafsson and Prof Cikes express their thoughts on the sub-analyses that identified a responder group, affirming its authenticity and significance. They also highlight the importance of the RESPONDER-HF confirmatory trial in validating the positive responder group outcomes observed in REDUCE LAP-HF II. These discussions contribute to a deeper understanding of HFpEF management and treatment options.
More from this programme
Part 1
REDUCE LAP-HF II Corvia Atrial Shunt 2-Year Outcomes | Clinician Commentary
Faculty Biographies
Finn Gustafsson
Professor of Cardiology
Finn Gustafsson, MD, PhD, DMSci, is a professor of cardiology at the University of Copenhagen and medical director of the advanced heart failure, transplantation and MCS program at Rigshospitalet in Copenhagen, Denmark. His clinical training in cardiology was conducted in Denmark and Canada. His research interests include several aspects of heart failure pathophysiology and management. He is an author of more than 300 peer reviewed articles in international scientific journals and several book chapters. Prof Gustafsson serves on the steering committee of several international clinical trials and registries within the field of advanced heart failure and HFpEF. He has served as an associate editor for several cardiology journals, including International Journal of Cardiology, Circulation: Heart Failure and European Journal of Heart Failure.
Maja Cikes
Associate Professor
Prof Maja Cikes is Associate Professor at University Hospital Centre Zagreb, HR. Prof Cikes has dedicated a significant portion of her career to advancing scientific knowledge in the field of cardiology. Her research interests span a wide range of topics, including cardiac imaging techniques, cardiovascular risk assessment, and the role of genetics in cardiovascular diseases.
She has authored numerous publications in prestigious medical journals, contributing to the collective understanding of cardiovascular medicine.
Comments